Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Long Term Debt 2008–2025
Regeneron Pharmaceuticals, Inc. annual/quarterly long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Regeneron Pharmaceuticals, Inc. long term debt for the quarter ending December 31, 2025 were 1.99B, a 0.08% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. long term debt for 2025 were 1.99B, a 0.08% increase from 2024.
- Regeneron Pharmaceuticals, Inc. long term debt for 2024 were 1.98B, a 0.08% increase from 2023.
- Regeneron Pharmaceuticals, Inc. long term debt for 2023 were 1.98B, a 0.08% increase from 2022.
- Regeneron Pharmaceuticals, Inc. long term debt for 2022 were 1.98B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Regeneron Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1,986 |
| 2024 | $1,984 |
| 2023 | $1,983 |
| 2022 | $1,981 |
| 2021 | $1,980 |
| 2020 | $1,979 |
| Regeneron Pharmaceuticals, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $1,986 |
| 2024-12-31 | $1,984 |
| 2023-12-31 | $1,983 |
| 2022-12-31 | $1,981 |
| 2021-12-31 | $1,980 |
| 2020-12-31 | $1,979 |
Regeneron Pharmaceuticals Inc. Long Term Debt — FAQ
Regeneron Pharmaceuticals Inc. (REGN) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's long term debt history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.